OMOP Concept 36924219
{(3 ML Lixisenatide 0.05 MG/ML Injectable Solution) / (3 ML Lixisenatide 0.1 MG/ML Injectable Solution) } Pack [Lyxumia]
StandardDrugRxNorm ExtensionOMOP5214658Branded Pack
Maps from
0
Descendants
1
Valid from
22 May 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(13)Roll up to these when you need a wider cohort.
- 13 ML Lixisenatide 0.05 MG/ML Injectable Solution
- 13 ML Lixisenatide 0.1 MG/ML Injectable Solution
- 1Lixisenatide 0.05 MG/ML Injectable Solution
- 1Lixisenatide 0.1 MG/ML Injectable Solution
- 2lixisenatide 0.05 MG/ML
- 2lixisenatide 0.1 MG/ML
- 2Lixisenatide Injectable Solution
- 3lixisenatide
- 3lixisenatide; parenteral
- 4Glucagon-like peptide-1 (GLP-1) analogues
- 5BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
- 6DRUGS USED IN DIABETES
- 7ALIMENTARY TRACT AND METABOLISM
Narrower concepts
(1)Included automatically when you query with descendants.
Get this concept via the API
Resolve {(3 ML Lixisenatide 0.05 MG/ML Injectable Solution) / (3 ML Lixisenatide 0.1 MG/ML Injectable Solution) } Pack [Lyxumia] - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/36924219?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card